These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
525 related items for PubMed ID: 15803631
1. International Conference on Harmonisation; guidance on E2E Pharmacovigilance Planning; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2005 Apr 01; 70(62):16827-8. PubMed ID: 15803631 [Abstract] [Full Text] [Related]
2. International Conference on Harmonisation; guidance on Q9 Quality Risk Management; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2006 Jun 02; 71(106):32105-6. PubMed ID: 16795933 [Abstract] [Full Text] [Related]
3. International Conference on Harmonisation; Guidance on S8 Immunotoxicity Studies for Human Pharmaceuticals; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2006 Apr 13; 71(71):19193-4. PubMed ID: 16612859 [Abstract] [Full Text] [Related]
5. International Conference on Harmonisation; guidance on good manufacturing practice for active pharmaceutical ingredients; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2001 Sep 25; 66(186):49028-9. PubMed ID: 12358036 [Abstract] [Full Text] [Related]
7. International Conference on Harmonisation; guidance on S7A safety pharmacology studies for human pharmaceuticals; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2001 Jul 13; 66(135):36791-2. PubMed ID: 12356097 [Abstract] [Full Text] [Related]
11. International Conference on Harmonisation; guidance on S7B Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2005 Oct 20; 70(202):61133-4. PubMed ID: 16237859 [Abstract] [Full Text] [Related]
12. International Conference on Harmonisation; Guidance on M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2010 Jan 21; 75(13):3471-2. PubMed ID: 20349552 [Abstract] [Full Text] [Related]
14. International Conference on Harmonisation; guidance on M4 common technical document; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2001 Oct 16; 66(200):52634-7. PubMed ID: 12358037 [Abstract] [Full Text] [Related]
15. International Conference on Harmonisation; guidance on E11 clinical investigation of medicinal products in the pediatric population; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2000 Dec 15; 65(242):78493-4. PubMed ID: 12362934 [Abstract] [Full Text] [Related]
16. International Conference on Harmonisation; choice of control group and related issues in clinical trials; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2001 May 14; 66(93):24390-1. PubMed ID: 12356096 [Abstract] [Full Text] [Related]
19. International Conference on Harmonisation; guidance on Addendum to E2C Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2004 Feb 05; 69(24):5551-2. PubMed ID: 14968802 [Abstract] [Full Text] [Related]
20. International Conference on Harmonisation; addendum to International Conference on Harmonisation Guidance on S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 2012 May 18; 77(97):29665-6. PubMed ID: 22616137 [Abstract] [Full Text] [Related] Page: [Next] [New Search]